This finding is in contrast to what has been observed during HIV-1 infection, where Env has been shown to evolve towards a denser glycan shield during the asymptomatic phase of the infection [17,26,27,28], only to lose glycans in end-stage disease [13]. The gene discussed is ERVW-1; the disease is infection.